J&J Buys Pfizer Consumer Division For $16.6 Bil.
This article was originally published in The Pink Sheet Daily
Executive Summary
Johnson & Johnson CEO William Weldon says the deal will make the firm's portfolio "more balanced," with 40% devoted to pharmaceuticals, 35% to medical devices and 25% to consumer products.